medizin.newzs.de
Targeting brain tumors: new drug candidate in clinical trial
Clinical trials are a milestone in the development of safe and effective drugs and therapies. An antibody developed by Helmholtz Munich is now entering a phase 1 clinical trial. Together with the r…